Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q4 2025 Update
Source: SeekingAlpha
2026-02-02 20:49:20 ET
This article is part of a series that provides an ongoing analysis of the changes made to Davis Selected Advisers’ 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 02/02/2026. Please visit our Tracking Christopher Davis’ Davis Selected Advisers 13F Portfolio series to get an idea of their investment philosophy and our previous update for the fund’s moves during Q3 2025....
Read the full article on Seeking Alpha
For further details see:
Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q4 2025 Update
Viatris Inc.
NASDAQ: VTRS
VTRS Trading
-1.46% G/L:
$14.195 Last:
2,942,277 Volume:
$14.04 Open:
VTRS Latest News
February 27, 2026 03:57:23 pm
Bastion Bets on Government Spending with $8 Million New Stake in Parsons
February 26, 2026 06:55:00 am
Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend
VTRS Stock Data
$18,451,353,349
1,140,252,173
N/A
503
N/A
Pharmaceuticals
Healthcare
US
Canonsburg
